Home|Journals|Articles by Year Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

Original Research

Ann Med Res. 1997; 4(1): 10-13


Investigation of Chlamydia trachomatis infection with two different methods and administration of azithromycin in treatment of the women with pelvic inflamatory disease

 

Dr. A. Süha Sönmez1, Dr. Emine Sönmez2, Dr. Bengül Durmaz3, Dr. Mehmet Körolu3, Dr. Hatice Özbilge3

 
.

Abstract

 


In this study, Chlamydia trachomatis was investigated by solid-phase immunassay (SIA) method (Chlamy-Check-1, Vedalab-France) in endocervical specimens of 106 patients with acute or chronic pelvic inflamatory disease (PID) who presented to Obstetrics and Gynaecology clinic of Research Hospital of nönü University. Fifty one of patients had acute and, remaining had chronic PID. Chlamydia antigen was positive in 4 of acute PID group (7.8%) and in 6 of chronic PID group (10.9%). Chlamydia antigen was also positive in the urethral swabs of husbands of 4 C. trachomatis positive women. Fourteen patients with Chlamydia infection recevied 1 gr single -oral dose of azithromycin. Chlamydia antigen was negative in the control specimens taken on the 7th-10h days of treatment except one patient (92.9%). Rapid diagnostic assays for C. trachomatis screening such as Chlamy-Check-1 can be prefered because it is easily to apply and a sensitive test. Single dose-1 gr azythromycin provided eradication of C. trachomatis antigen in 92.9% of patients and their partners who were found C. trachomatis antigen positive. Further studies with doxycycline and erythromycin are needed to be able to offer azythromycin administration safely in PID cases with C. trachomatis antigen positive. As a conclusion, C. trachomatis should be investigated in patients with acute and chronic PID. [Journal of Turgut Özal Medical Center 1997;4(1):10-13]

Key Words: Chlamydial infection, azithromycin, PID


Full-text options

Full-text Article




Advertisement
Archives of Clinical and Experimental Surgery (ACES)

SUBMIT YOUR ARTICLE NOW




ScopeMed.com
BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.